New York Times Changes Tune—Admits That Unvaccinated At Less Risk Than Vaccinated

We have been telling people this for what seems like years now.

These vaccines aren’t really vaccines at all; they can best be described as mild therapeutics—just like the flu shot.

Vaccinated individuals carry a much greater viral load according to some experts and pundits. This has been well documented in studies which suggest that the Covid-19 shot may be more of a liability than an aid.

The latest reports from The New York Times indicate a change in tune from their previously held establishment position that vaccines were the best way in stopping the spread of the virus.

The New York Times recently wrote:

By the week beginning Oct. 3, however, vaccinated people with a prior diagnosis fared best against the Delta variant.

Unvaccinated people with a history of Covid also had lower rates of infection and hospitalization than those protected by vaccines alone.

New York Times Admits Unvaxxed People Have 'Lower Rates of Infection And Hospitalization' Of COVID-19 Than The Vaxxed. https://t.co/WtFAxcElhk

— Raheem. (@RaheemKassam) January 27, 2022

Censor 👇

New York Times Admits Unvaxxed People Have ‘Lower Rates of Infection And Hospitalization’ Of COVID-19 Than The Vaxxed.

The data are consistent with trends observed in international studies, the researchers said,” added The New York Times.

— 🇺🇸Robert.N🇺🇸 (@Rob_Noorollah) January 28, 2022

The truth has come out way too late on this one, but we in the independent media have been reporting on this for some time now. Stop lying. Stop calling people anti-vaxxers, white nationalists, etc. #NewYorkTimes#VaccineMandate #VaccineSideEffects @pfizer @POTUS https://t.co/IPZItv3FR6

— Vince Quill (@VinceQuill) January 28, 2022

The National Pulse points out:

The admission follows other studies showing similar trends, including a Robert Koch Institute report that found nearly 80 percent of Omicron cases occurred in vaccinated individuals.

The story also follows an unprecedented surge in lobbying efforts by American pharmaceutical giants that developed COVID-19 shots including Pfizer and Moderna.